Dacheng Jingheng Mixed C Net Worth Down 3.76% Earnings_Sina Finance_Sina.com Post date April 27, 2022 — 07:41 Post Lock Read More Dacheng Jingheng Mixed A Net Worth Down 3.75% Earnings_Sina Finance_Sina.com Post date April 27, 2022 — 07:28 Post Lock Read More Dacheng Jingheng Mixed A Net Worth Down 7.47% Earnings_Sina Finance_Sina.com Post date April 26, 2022 — 07:59 Post Lock Read More Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations_ Oriental Fortune Net Post date April 25, 2022 — 10:49 Post Lock Read More Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations. Post date April 25, 2022 — 10:48 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Dacheng Jingheng Mixed A Net Worth Down 3.75% Earnings_Sina Finance_Sina.com Post date April 27, 2022 — 07:28 Post Lock Read More Dacheng Jingheng Mixed A Net Worth Down 7.47% Earnings_Sina Finance_Sina.com Post date April 26, 2022 — 07:59 Post Lock Read More Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations_ Oriental Fortune Net Post date April 25, 2022 — 10:49 Post Lock Read More Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations. Post date April 25, 2022 — 10:48 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Dacheng Jingheng Mixed A Net Worth Down 7.47% Earnings_Sina Finance_Sina.com Post date April 26, 2022 — 07:59 Post Lock Read More Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations_ Oriental Fortune Net Post date April 25, 2022 — 10:49 Post Lock Read More Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations. Post date April 25, 2022 — 10:48 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations_ Oriental Fortune Net Post date April 25, 2022 — 10:49 Post Lock Read More Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations. Post date April 25, 2022 — 10:48 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical: The company's non-public offering projects are carried out in strict accordance with relevant regulatory regulations, and there is no violation of laws and regulations. Post date April 25, 2022 — 10:48 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical (603590.SH) released its 2021 results with a net profit of 148 million yuan, a year-on-year decrease of 19.29% Post date April 22, 2022 — 21:33 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical (603590.SH) released its first-quarter results and net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical (603590.SH) released its first-quarter results with a net profit of 46.437 million yuan, a year-on-year decrease of 27.89% – yqqlm Post date April 22, 2022 — 21:28 Post Lock Read More Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Announcement of Beijing Kangchen Pharmaceutical Co., Ltd. on Obtaining Government Subsidies Post date April 16, 2022 — 08:25 Post Lock Read More Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Wantai Bio: Appoint Xie Bo as Secretary of the Board of Directors Post date April 15, 2022 — 23:08 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Tablet Chinese Medicine Asset Management Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 17:35 Post Lock Read More Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical intends to purchase Hemu Zhongchuang Jincao Pian Chinese Medicine Assets Financial Channel Rongyi Information Network for 134 million yuan Post date April 10, 2022 — 16:53 Post Lock Read More [Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[Kangchen Pharmaceutical] Introduced innovative traditional Chinese medicine for chronic pelvic pain and opened up the blue ocean segment_Financial News Financial Times Post date April 10, 2022 — 07:48 Post Lock Read More Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Caitong Securities: Give Kangchen Pharmaceutical an Overweight Rating_Stock News_Market Gold Online Post date April 9, 2022 — 16:45 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan Post date April 8, 2022 — 21:07 Post Lock Read More Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Kangchen Pharmaceutical intends to purchase the traditional Chinese medicine assets of Hemu Zhongchuang Jincao Pian for 134 million yuan-Stock Channel-Hexun.com Post date April 8, 2022 — 20:58 Post Lock Read More 53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
53 stocks received institutional buy ratings today, 5 stocks have upside potential of more than 50% Teller Report Teller Report Post date April 8, 2022 — 19:47 Post Lock Read More 53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
53 stocks were rated as buy by institutions today, 5 stocks rose by more than 50%_Oriental Fortune Network Post date April 8, 2022 — 17:43 Post Lock Read More
Caishen.CoCaishen.Co